Germany Imports 201 Tonnes of Medical Cannabis in 2025 and Crosses €1 Billion in Sales
Germany’s pharmacy sell-out market surpassed €1 billion for the first time in 2025, with imports reaching a record 201.1 tonnes (+176% YoY) — making it the largest regulated medical cannabis market globally. This data brief examines the supply chain diversification that accompanied that growth, the regulatory and pricing pressures now reshaping the operator landscape, the […]
Czechia’s medical cannabis programme gains momentum as GP reform widens access
Czechia’s medical cannabis programme grew 46% in 2025—the strongest year since 2021. Full-year SÚKL data confirms the GP reform partially worked: prescribing doctors rose 28% to 305, flower grew 35% (233 → 314 kg), and the extract market more than doubled (30 → 76 kg). Domestic EU-GMP producers now anchor supply, while Czech infrastructure increasingly […]
Historic regulatory pivots meet market caution — December 2025
Thank you for being a Cannamonitor subscriber. You have full access to this brief—over 300 December updates across 45+ markets—plus our complete searchable database of 7,000+ regulation, market and science sources: in the Insights section you’ll get access as well to the M&A Tracker mentioned below. December 2025 delivered the most significant US federal cannabis policy shift […]
Hemp Under Siege, Telemedicine Squeezed — November 2025 Brief
Hemp and CBD restrictions reshape access and redraw the global cannabis geoeconomy
Legalisation Momentum Meets Regulatory Headwinds — October 2025 Brief
Access the database with +5,000 regulation updates, market reports and science papers on the international cannabis market. October 2025 highlighted a decisive shift toward regulatory expansion across the global cannabis landscape. Import quotas rose, hospital and pharmacy access widened, and several countries advanced long-awaited legal frameworks — signalling renewed political momentum. Yet these openings coexist with […]
Spain’s CBD Boom Faces Hemp Sector Collapse and Regulatory Limbo
Between 2018 and 2023, Spain built one of Europe’s most dynamic CBD consumer markets. Revenues more than doubled, specialist shops appeared in every large city, and Spanish brands started exporting to neighbouring countries. Yet in the same period, the country almost eradicated the hemp crops that should be feeding that demand. What should be a […]
Spain Legalises Medical Cannabis: Patient Access Is the Next Frontier
After years of political delay and institutional hesitation, Spain has finally taken a decisive step toward a regulated medical cannabis system. Royal Decree 903/2025, published this summer, establishes the country’s first comprehensive framework for therapeutic use — a turning point that begins to align Spain with other advanced European markets. This article examines the foundations […]
Regulatory scrutiny fuels market instability — September 2025 Brief
September 2025 underscored the tension between rising demand and tightening compliance across global cannabis supply chains. Imports, prescriptions, and economic contributions continue to climb, yet regulatory reviews multiply — with stricter prescribing rules and compliance crackdowns reshaping access. Some countries move boldly toward reform, while others drift in regulatory grey zones — marking a sector entering […]
Australia’s Cannabis Market Transition: Booming Supply, Tightening Rules
Australia’s medical cannabis market continues to grow at an impressive pace, yet it faces a series of regulatory, clinical, and supply-side inflection points that are shaping the sector’s trajectory. Despite a growing scale and further maturation of the market, challenges remain in terms of patient safety, prescriber oversight, and domestic supply competitiveness. This feature article […]
Global Market Grows Under Tightening Rules – August 2025 Brief
Diverging access and mounting constraints define the next phase of global cannabis amid fragile supply chains.